Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, Covaris Ink Co-marketing Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Covaris announced today that it has signed a co-marketing deal with Illumina related to sequencing sample preparation.

Under the agreement, the firms will co-market Covaris' DNA shearing technologies with Illumina's next-generation sequencing product lines including the HiSeq, HiScanSQ, and Genome Analyzer.

According to Woburn, Mass.-based Covaris, its technology "enables higher recoveries for nucleic acid extraction, tissue homogenization, chromatin shearing, protein digestion, and cell lysis." It also is isothermal and non-contact, which ensures molecular stability.

Financial and other terms of the alliance were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more